Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Cantor Fitzgerald
Express Scripts
Johnson and Johnson
Daiichi Sankyo

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017106

« Back to Dashboard
NDA 017106 describes ATROPEN, which is a drug marketed by Meridian Medcl Techn and is included in one NDA. It is available from one supplier. Additional details are available on the ATROPEN profile page.

The generic ingredient in ATROPEN is atropine. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine profile page.

Summary for NDA: 017106

Formulation / Manufacturing:see details

Pharmacology for NDA: 017106

Suppliers and Packaging for NDA: 017106

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INJECTABLE;INJECTION 017106 NDA Meridian Medical Technologies, Inc. 11704-104 11704-104-01 .7 mL in 1 SYRINGE, GLASS (11704-104-01)
INJECTABLE;INJECTION 017106 NDA Meridian Medical Technologies, Inc. 11704-105 11704-105-01 .7 mL in 1 SYRINGE, GLASS (11704-105-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2MG SULFATE/0.7ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1MG SULFATE/0.7ML
Approval Date:Jun 19, 2003TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 0.5MG SULFATE/0.7ML
Approval Date:Jun 19, 2003TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus